Article
Preclinical Testing of Antihuman CD28 Fab' Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease.
Transplantation - 1 Dec 2016
Hippen Keli L, Watkins Benjamin, Tkachev Victor, Lemire Amanda M, Lehnen Charles, Riddle Megan J, Singh Karnail, Panoskaltsis-Mortari Angela, Vanhove Bernard, Tolar Jakub, Kean Leslie S, Blazar Bruce R
Abstract excerpt
BACKGROUND: Graft-versus-host disease (GVHD) is a severe complication of hematopoietic stem cell transplantation. Current therapies to prevent alloreactive T cell activation largely cause generalized immunosuppression and may result in adverse drug, antileukemia and antipathogen responses. Recently, several immunomodulatory therapeutics have been developed that show efficacy in maintaining antileukemia responses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
